GENELUX CORPORATION Short-term Debt
GENELUX CORPORATION (GNLX) had Short-term Debt of $900.00 thousand as of 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ShortTermBorrowings · last filed 2025-03-28
- 2023-12-31: Short-term Debt $900.00K.
- 2023-09-30: Short-term Debt $900.00K.
- 2023-06-30: Short-term Debt $900.00K.
- 2023-03-31: Short-term Debt $900.00K.
| Period end | Short-term Debt |
|---|---|
| 2023-12-31 | $900.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $900.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $900.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |